Switch theme
Sign up to access all valuation multiples
Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze, and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.
1999
1.2K+
LTM Revenue $425M
LTM EBITDA $105M
$4.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Cellebrite has a last 12-month revenue of $425M and a last 12-month EBITDA of $105M.
In the most recent fiscal year, Cellebrite achieved revenue of $401M and an EBITDA of $67.5M.
Cellebrite expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Cellebrite valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $325M | $401M | XXX | XXX | XXX |
| Gross Profit | $220M | $272M | XXX | XXX | XXX |
| Gross Margin | 68% | 68% | XXX | XXX | XXX |
| EBITDA | -$65.4M | $67.5M | XXX | XXX | XXX |
| EBITDA Margin | -20% | 17% | XXX | XXX | XXX |
| Net Profit | $121M | -$81.1M | XXX | XXX | XXX |
| Net Margin | 37% | -20% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Cellebrite's stock price is $19.
Cellebrite has current market cap of $4.6B, and EV of $4.1B.
See Cellebrite trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4.1B | $4.6B | XXX | XXX | XXX | XXX | $-0.88 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Cellebrite has market cap of $4.6B and EV of $4.1B.
Cellebrite's trades at 9.7x LTM EV/Revenue multiple, and 39.3x LTM EBITDA.
Analysts estimate Cellebrite's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Cellebrite and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $4.1B | XXX | XXX | XXX |
| EV/Revenue | 10.3x | XXX | XXX | XXX |
| EV/EBITDA | 61.1x | XXX | XXX | XXX |
| P/E | -16.1x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 33.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpCellebrite's NTM/LTM revenue growth is 20%
Cellebrite's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Cellebrite's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Cellebrite's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Cellebrite and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 23% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -203% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 36% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 33% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 13% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 25% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 70% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| archTIS | XXX | XXX | XXX | XXX | XXX | XXX |
| FirstWave | XXX | XXX | XXX | XXX | XXX | XXX |
| Prophecy International | XXX | XXX | XXX | XXX | XXX | XXX |
| Qoria | XXX | XXX | XXX | XXX | XXX | XXX |
| Quick Heal | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cellebrite acquired XXX companies to date.
Last acquisition by Cellebrite was XXXXXXXX, XXXXX XXXXX XXXXXX . Cellebrite acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Cellebrite founded? | Cellebrite was founded in 1999. |
| Where is Cellebrite headquartered? | Cellebrite is headquartered in United States of America. |
| How many employees does Cellebrite have? | As of today, Cellebrite has 1.2K+ employees. |
| Who is the CEO of Cellebrite? | Cellebrite's CEO is Mr. Thomas E. Hogan. |
| Is Cellebrite publicy listed? | Yes, Cellebrite is a public company listed on NAS. |
| What is the stock symbol of Cellebrite? | Cellebrite trades under CLBT ticker. |
| When did Cellebrite go public? | Cellebrite went public in 2021. |
| Who are competitors of Cellebrite? | Similar companies to Cellebrite include e.g. archTIS, FirstWave, Prophecy International, Qoria. |
| What is the current market cap of Cellebrite? | Cellebrite's current market cap is $4.6B |
| What is the current revenue of Cellebrite? | Cellebrite's last 12-month revenue is $425M. |
| What is the current EBITDA of Cellebrite? | Cellebrite's last 12-month EBITDA is $105M. |
| What is the current EV/Revenue multiple of Cellebrite? | Current revenue multiple of Cellebrite is 9.7x. |
| What is the current EV/EBITDA multiple of Cellebrite? | Current EBITDA multiple of Cellebrite is 39.3x. |
| What is the current revenue growth of Cellebrite? | Cellebrite revenue growth between 2023 and 2024 was 23%. |
| Is Cellebrite profitable? | Yes, Cellebrite is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
